Clinical trial

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

NCT02634008

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE3

Study timeline

Study start (actual)2016-06-01Date precision: month

Registry last updated2022-08-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C, Acuteunresolved

Interventions

Paritaprevir/ritonavir/ombitasvirDRUG

DasabuvirDRUG

RibavirinDRUG · verified · RxNorm: ribavirin

Glecaprevir/pibrentasvirDRUG

Sponsors & collaborators

Kirby Institutelead sponsor

AbbViecollaborator

Mapped research locations

LondonUnited Kingdom5 ManchesterUnited Kingdom1 MelbourneVictoria, Australia1 AdelaideSouth Australia, Australia1 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02634008 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.